Hydrocortisone sodium succinate injection Ip


Product Details
img
Name Of Product(Genric Name) :

Hydrocortisone sodium succinate injection Ip

Dosage :

100MG/500MG

Product Description :

HYDROCORTISONE SODIUM SUCCINATE INJECTION IP 100 mg / 500 mg

Sterile Powder for Solution for Intravenous or Intramuscular Administration

  1. COMPOSITION

Each vial contains:

Hydrocortisone Sodium Succinate equivalent to Hydrocortisone ............... 100 mg

or

Hydrocortisone Sodium Succinate equivalent to Hydrocortisone ............... 500 mg

Excipients: As applicable.

  1. PHARMACEUTICAL FORM

Sterile, white to off-white powder for solution for intravenous or intramuscular administration.

  1. THERAPEUTIC CLASS

Corticosteroid / Glucocorticoid

  1. INDICATIONS

Hydrocortisone Sodium Succinate Injection is indicated when rapid systemic corticosteroid therapy is required or when oral administration is not feasible.

It may be used in the treatment of:

• Severe allergic and hypersensitivity reactions
• Acute adrenal insufficiency
• Rheumatic and inflammatory disorders
• Severe dermatological disorders
• Respiratory disorders
• Autoimmune conditions
• Other corticosteroid-responsive conditions as clinically appropriate

Treatment should be used according to the approved prescribing information.

  1. CONTRAINDICATIONS

Hydrocortisone Sodium Succinate is contraindicated in patients with known hypersensitivity to hydrocortisone or any component of the formulation.

Systemic fungal infections are also a contraindication unless corticosteroid therapy is specifically indicated.

  1. DRUG INTERACTIONS

Particular consideration may be required with concomitant use of:

• Antidiabetic medicines
• Anticoagulants
• Diuretics
• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Medicines affecting corticosteroid metabolism
• Certain vaccines

The treating physician should review all concomitant medications before administration.

  1. ADMINISTRATION

Hydrocortisone Sodium Succinate Injection may be administered by intravenous or intramuscular route according to the approved product information.

The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.

The reconstituted solution should be administered by a qualified healthcare professional according to the approved product information and institutional protocol.

For Intravenous or Intramuscular Use Only.

  1. STORAGE

Store according to the storage conditions stated on the approved product label.

Protect from excessive heat, moisture and light.

After reconstitution, use within the period specified in the approved product information.

Do not use if the reconstituted solution shows visible particles, precipitation or unexpected discoloration.